CIP2A/p90 Autoantigen Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
Oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.
Synonyms
P90; CIP2A; Protein CIP2A; Cancerous inhibitor of PP2A; p90 autoantigen; KIAA1524
Gene ID
57650
Swiss Prot
Q8TCG1
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
601-700/905
Target
CIP2A/p90 Autoantigen
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human CIP2A/p90 Autoantigen
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
57650
Predicted Cross Reactivity
Mouse, Rat, Dog, Cow, Rabbit
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC051037-100 1x 100 µL
CD44 Standard (DF1485), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471150-100 1x 100 µL
Cytokeratin 19 (KRT19/799 + KRT19/800), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details